Skip to main content

A pathogenic COL7A1 variant highlights semi-dominant inheritance in dystrophic epidermolysis bullosa

Abstract

Dystrophic epidermolysis bullosa is a rare subtype of inherited epidermolysis bullosa, caused by variants in the collagen type VII alpha 1 chain (COL7A1) gene (MIM120120). Both autosomal dominant and recessive inheritance has been reported with variable phenotype. We investigated a Pakistani family with dystrophic epidermolysis bullosa via exome sequencing and identified a pathogenic nonsense variant in COL7A1 NM_000094 c.1573 C > T:p.(Arg525*). The inheritance pattern observed was consistent with a semi-dominant model, where heterozygous parents exhibited a mild phenotype, and homozygous children were more severely affected. For dystrophic epidermolysis bullosa, loss-of-function variants are typically associated with the autosomal recessive form, while missense variants are linked to the autosomal dominant form. A review of the literature suggests a semi-dominance pattern for some missense variants, particularly glycine substitutions, but this concept had not been formally recognized. This study highlights the importance of considering semi-dominant inheritance models for dystrophic epidermolysis bullosa and other Mendelian diseases with an autosomal recessive mode of inheritance, as it can significantly impact diagnosis and genetic counseling.

Peer Review reports

Introduction

Mendelian diseases are characterized by single-gene inheritance, while non-Mendelian patterns arise from more complex interactions involving genetic, environmental, or epigenetic factors. Even in seemingly straightforward Mendelian cases, considering non-Mendelian models is essential for achieving accurate diagnoses, risk assessments, and providing effective genetic counseling.

Hereditary epidermolysis bullosa (EB), is a wide group of rare genodermatoses characterized by mild to severe fragility of epithelial tissues which extends to erosions and blistering of the skin, skin fragility, milia, crusting and scarring of the skin, and nail dystrophy [1, 2]. Severe scarring on the hands and feet is frequently linked to the onset of aggressive squamous-cell carcinomas that spread quickly, potentially leading to early death [3]. Based on the level of blistering, target proteins, and clinical symptoms, EB is divided into four broad groups [2], Epidermolysis Bullosa simplex (EBS) [1] junctional Epidermolysis Bullosa (JEB) (MIM226650) [4], dystrophica Epidermolysis Bullosa (DEB)(MIM226600), and Kindler Epidermolysis Bullosa (KEB) [5]. However, there are more than 30 distinct subtypes based on clinical heterogeneity, variant analysis and immunofluorescence mapping [4]. Dystrophic EB (DEB) is caused by variants in COL7A1 (MIM120120) and affects ectodermal appendages, i.e., skin, hair, nail, and teeth. Segregation shows results with either an autosomal recessive (AR) or autosomal dominant (AD) modes of inheritance. With missense variant mainly associated with AD inheritance patterns and loss-of-function variants with AR disease [6]. For the DDEB, blistering tends to be relatively mild and localized while RDEB is more severe, with widespread blistering that can have complications [7, 8]. Both molecular diagnosis and genotype-phenotype correlations are DEB challenging due to phenotypic heterogeneity, the diverse range of variants which include de novo events.

A large study of 310 families with DDEB and RDEB, found that 48 families (15.5%) had DDEB, which was confirmed by family history or identification of known or de novo variants. The remaining 262 families (84.5%) had RDEB. Notably, a subset of seven patients (2.3%) which were member or RDEB families with unusual intrafamilial phenotypic heterogeneity were found to be compound heterozygous for an AR and AD variant [6]. Furthermore, certain glycine substitutions in COL7A1 have been reported to cause both AD and AR disease [9].

Type VII collagen is mainly produced by epidermal keratinocytes, with dermal fibroblasts also contributing [10]. It forms a homotrimeric monomer intracellularly and assembles into antiparallel dimers after secretion. These dimers aggregate into anchoring fibrils that connect the epidermal basement membrane to the dermis, ensuring structural integrity [11,12,13].

EB, which primarily affects children, is observed in all genders and ancestries with an estimated prevalence of about half a million individuals worldwide [14, 15]. Symptoms typically appear at or shortly after birth and persist throughout life, though some may not manifest until early adulthood. Currently, there are no approved treatments for EB; management focuses on symptom control, wound care, and preventing complications, with additional support for feeding difficulties and overall care [2, 16].

We investigated a clinically well-characterized Pakistani family with DEB via exome sequencing, revealing a pathogenic nonsense variant c.1573 C > T:p.(Arg525*) in COL7A1 that follows a semi-dominant inheritance pattern. For semi-dominant inheritance (also known as incomplete dominance or partial dominance) individuals who are heterozygous have a less serve phenotype than individuals who are either homozygous or compound heterozygous.

Materials and methods

Ethical approval

Institutional review board approval was obtained from Hazara University Mansehra, Pakistan (IF.No.HU/ORIC/2023/1230) and Columbia University New York, USA (AAAS3431). Informed consent was obtained from adult study subjects, and the parents/legal guardians of individuals under the age of 18.

Clinical assessment

The family under study (ED-5) is of Pashtun ancestry was ascertained in khyber Pakhtukhawa, Pakistan (Fig. 1). The consanguineous family has a total of four affected, parents and children. Parents (II:5 and II:6) have a mild phenotype and affected children (III:1 and III:2) are more severely affected. III:1, died a few days of after birth and was therefore not included in the present study. Affected member III:3 also died shortly after birth, but a DNA sample was obtained. All affected members were examined by a local dermatologist (Fig. 2). Phenotypic information for all affected family members is noted in detail (Table 1).

Fig. 1
figure 1

Pedigree of family ED-5 (COL7A1). The consanguineous pedigree with segregation of the COL7A1 [c.1573 C > T:p.(Arg525*)] variant. Squares indicate the males, circles female and filled black filed symbols represent individuals with severe dystrophic epidermolysis bullosa and grey filled symbols individuals with a milder form of dystrophic epidermolysis bullosa. Double lines indicate consanguinity and individuals with a line through the symbol indicates they are deceased

Fig. 2
figure 2

Clinical presentation. Images (A-D) show nail dystrophy, Beau’s lines, club nails and dry skin of the affected father (II:6), images (E) and (F) display the black tartar teeth of the affected mother (II:5) and images (G-L) show the phenotypes of affected child (II:2), image (G-I) shows blistering all over the left and right foot, erosions and erythematous skin, dryness, image (J) dryness and blisters on hands image (K) shows nail dystrophy and club nails of affected child, image (L) shows skin dryness, milia, and a yellowish crusted lesion present on the ear

Exome sequencing and bioinformatic analysis

Blood samples were collected from the affected parents (II:5 and II:6) and the affected child (III:2). DNA extraction was done using phenol-chloroform. Genomic DNA of the affected member (III:2) was exome sequenced using the Agilent sure select Human All exon V6 kit (Agilent technologies, Santa Clara, CA, USA). Barcoded libraries were pooled, and sequencing was performed on the Illumina Novaseq6000 with an average targeted depth of 105.66x.

Filtered reads were aligned to GRCh38/ hg38 using the Burrows-Wheeler aligner (BWA) [17]. Picard was used for duplicate removal. Variant calling and quality recalibration were performed using the genome analysis toolkit (GATK) [18]. Variants were annotated using ANNOVAR [19]. The criteria for variant selection included being exonic or within the splice region (± 12 bp) and having a minor allele frequency (MAF) < 0.005 in every gnomAD population [20]. An AR model of inheritance was first considered due to the pedigree structure, but other models were also considered. Copy number variants were also investigated using CoNIFER [21].

Sanger sequencing

The COL7A1 variant that was detected in the exome sequence data was validated and tested for segregation using DNA samples from all available family members using Sanger sequencing. Primers were designed for the variant of COL7A1 gene, where there putatively causal variant laid, using Primer3 [22]. PCR-amplified products were purified and sequenced. The DNA sequences were then aligned to the reference genome sequence using the Codon Code Aligner v7.1.2.

Results

Clinical investigation

An 8-day-old boy (III:2) from the family had a history of abnormal blisters covering his skin, along with erosions and erythema. He also had blisters in his mouth, making feeding difficult. Additionally, he exhibited milia on his hands, nail dystrophy, yellowish crusted lesions on his ears, and clubbed nails (Fig. 2I-L). He died a few days after birth. The child’s mother exhibits a mild phenotype, including dry skin, black tartar on her teeth leading to edentulism, decay, and pain. She had several tartar-covered teeth extracted due to the pain (Fig. 2E, F). The child’s father has dry skin and nail dystrophy, including clubbed nails, and Beau’s lines (Fig. 2A-D).

Exome sequencing

Exome sequencing identified a known pathogenic variant with c.1573 C > T:p.(Arg525*) with CADD score of 36 in exon13 in the COL7A1 gene, which was tested for segregation. Family members (II:5 and II:6) were heterozygous for the COL7A1 variant and their child (III.2) carried homozygous alleles. Phenotypic analysis and segregation results indicate a semi-dominant inheritance pattern for the family. The variant was classified as pathogenic according to American College of Medical Genetics (ACMG) guidelines (PVS1, PS1) [23]. The nonsense variant p.(Arg525*) is predicted to lead to a loss-of-function via nonsense-mediated decay [24].

Discussion

EB is a group of genetic disorders that are characterized by mechanically induced blistering and fragility of the skin which includes DEB (MIM 226600) that typically manifests at birth and impacts the skin, nails, teeth and hairs. For DEB there is extensive genetic and phenotypic heterogeneity. Genetic interactions, cellular modifications, and environmental influences may vary phenotype expression [25].

Anchoring fibrils, composed of collagen VII, attach the epidermal basement membrane to the underlying dermal connective tissue and are synthesized by epidermal keratinocytes as procollagen VII, which is then processed into functional collagen VII [11, 26, 27]. This collagen VII undergoes proteolytic trimming, forms disulfide-bonded antiparallel dimers, aggregates into anchoring fibrils, and interacts with laminin 5 to stabilize dermo-epidermal adhesion, with further stabilization provided by cross-linking via transglutaminase-2 [28]. While severe forms of DEB may lack both collagen VII and anchoring fibrils, milder forms exhibit altered fibril morphology with presences of collagen VII [26]. Variants in COL7A1, that encodes collagen VII, are found in both DDEB and RDEB subtypes, leading to varying degrees of skin blistering and scarring. Despite identifying numerous variants, the precise biological consequences and pathogenic mechanisms remain unclear [29, 30].

We studied a Pakistani family via exome sequencing and detected a pathogenic nonsense variant c.1573 C > T:p.(Arg525*) in the COL7A1 gene that inherits with a semi-dominant mode of inheritance. Semi-dominance, (aka incomplete dominance or partial dominance) is a condition where the phenotype for heterozygote carriers is intermediate between the homozygous or compound heterozygous phenotypes. This raises awareness in the medical community, as it formally acknowledges semi-dominant inheritance in DEB for the first time. This is crucial for accurate genetic counseling, diagnosis, and patient management, particularly in populations where consanguinity may impact the inheritance patterns of rare genetic conditions.

The COL7A1 nonsense variant, c.1573 C > T:p.(Arg525*), was previously identified in two Pakistani families with severe DEB. They were reported to have a similar phenotype including skin blisters, erosions, erythematous skin, oral blisters, and nail dystrophy [Table 1] [31, 32]. One of the proband’s elder brothers had also died eight days after his birth due to the same severe clinical features as was observed in our family, ED-5. However, unaffected heterozygous family members were not reported to have any phenotypes related to DEB in these previous studies. In our study, heterozygous parents show a milder phenotype but with some overlap with the phenotype of the homozygous case, including dry skin, nail dystrophy, and club nails. These mild features may be easily overlooked in clinical investigations of heterozygous individuals believed to be unaffected carriers.

We next performed a review of the literature to determine if potentially other semi-dominant DEB cases have been reported (Table 2). One COL7A1 variant, p.(Gly1770Ser), was reported as homozygous in two brothers with a severe DEB phenotype, while the phenotype for their heterozygous parents was mild. The father had nail dystrophy without skin blistering, while the mother had nail dystrophy, blistering, and inflammation on her shins, consistent with pretibial DEB. No DEB phenotypes were reported for the parents of a distant affected cousin.

Also reported in the literature was a family with compound heterozygous COL7A1 variants [p.(Pro1701Argfs*9) and p.(Gly2351Arg)] with a mild to severe DEB phenotypes: severely affected twins that were compound heterozygous for both variants (Table 2). The mother and maternal grandfather who were heterozygous for the missense variant p.(Gly2351Arg) showed a semi-dominant profile, while the father who carried the frameshift variant did not present with any DEB phenotypes. The heterozygous mother had erosions on the forearm and shedding of the toenails while the maternal grandfather had clinically abnormal nail loss and blisters on the hand (Table 2) [33].

Glycine substitutions within the type VII collagen triple helix have previously been reported to lead to either AD or AR phenotypes in unrelated patients, causing challenges in molecular diagnosis. Only investigation of larger families provided the evidence that the variants [p.(Gly1770Ser) and p.(Gly2351Arg)] are inherited with a semi-dominant mode of inheritance. These glycine substitutions can disrupt the biosynthesis of collagen VII in a dominant-negative manner. The biological consequences of substitutions likely depend on the specific position of glycine within the triple helix [9].

This study not only enhances the understanding of DEB but also emphasizes the need to consider a semi-dominant inheritance model. This inheritance pattern might be present in other Mendelian diseases, potentially leading to new insights and more effective management approaches. Expanding research on the phenotypic and genotypic spectrum of DEB is crucial for developing effective clinical and genetic therapies.

Consanguineous marriages significantly increase the likelihood of inheriting rare recessive variants due to shared ancestry, raising the prevalence of conditions like DEB. In Pakistan, where EB is prevalent and consanguineous marriages are common, patients face significant treatment challenges due to limited healthcare resources. This highlights the importance of genetic counseling for DEB families within the specific cultural and social context of Pakistan. Tailoring counseling efforts to address the social norms, perceptions of genetic diseases, and concerns about genetic testing can significantly improve patient understanding and adherence to treatment plans.

In conclusion, this study empowers individuals and families to understand and address the potential genetic implications of cousin marriages, ultimately help in reducing the genetic disorders in future generations, enhances the understanding of DEB but also emphasizes the need to consider complex inheritance patterns in genetic diseases. This approach can lead to better diagnostic accuracy, more informed genetic counseling, and improved patient care.

Table 1 Phenotype of individuals with homozygous and heterozygous COL7A1 c.1573 C > T:p.(Arg525*) variants
Table 2 Variants in COL7A1 consistent with semi-dominant inheritance in additional families

Data availability

The variant was deposited in ClinVar under accession number SCV005328388.

Abbreviations

BWA:

Burrows-wheeler aligner

CADD:

Combined annotation dependent depletion

COL7A1:

Collagen type VII alpha 1 chain

DNA:

Deoxyribonucleic acid

DDEB:

Dominant dystrophic epidermolysis bullosa

DEB:

Dystrophic epidermolysis bullosa

EB:

Epidermolysis bullosa

EBS:

Epidermolysis bullosa simplex

JEB:

Junctional epidermolysis bullosa

KEB:

Kindler epidermolysis bullosa

GATK:

Genome analysis tool kit

MAF:

Minor allele frequency

PCR:

Polymerase chain reaction

RDEB:

Recessive dystrophic epidermolysis bullosa

References

  1. Fine JD. Epidermolysis bullosa: clinical, epidemiologic, and laboratory advances, and the findings of the National Epidermolysis Bullosa Registry. Baltimore: Johns Hopkins University; 1999.

    Google Scholar 

  2. Fine JD, Eady RAJ, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, et al. The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on diagnosis and classification of EB. J Am Acad Dermatol. 2008;58(6):931–50.

    Article  PubMed  Google Scholar 

  3. Fine JD. Inherited epidermolysis bullosa. Orphanet J Rare Dis. 2010;5(1):12.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Fine JD, Bruckner-Tuderman L, Eady RAJ, Bauer EA, Bauer JW, Has C, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70(6):1103–26.

    Article  PubMed  Google Scholar 

  5. Has C, Bauer JW, Bodemer C, Bolling MC, Bruckner-Tuderman L, Diem A, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol. 2020;183(4):614–27.

    Article  CAS  PubMed  Google Scholar 

  6. Varki R, Sadowski S, Uitto J, Pfendner E. Epidermolysis Bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J Med Genet. 2006;44(3):181–92.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hashimoto I, Gedde-Dahl T, Schnyder UW, Anton-Lamprecht I. Ultrastructural studies in epidermolysis bullosa hereditaria: II. Dominant dystrophic type of cockayne and touraine. Arch Derm Res. 1976;255(3):285–95.

    Article  CAS  Google Scholar 

  8. Hashimoto I, Anton-Lamprecht I, Gedde-Dahl T, Schnyder UW. Ultrastructural studies in epidermolysis bullosa hereditaria: I. Dominant dystrophic type of pasini. Arch Derm Res. 1975;252(3):167–78.

    Article  CAS  Google Scholar 

  9. McGrath J, Almaani N, Liu L, Dopping-Hepenstal P, Lai-Cheong J, Wong A, et al. Identical Glycine substitution mutations in type VII collagen May Underlie both Dominant and recessive forms of Dystrophic Epidermolysis Bullosa. Acta Derm Venerol. 2011;91(3):262–6.

    Article  PubMed  Google Scholar 

  10. Ryynanen J, Sollberg S, Olsen DR, Uitto J. Transforming growth factor-β up-regulates type VII collagen gene expression in normal and transformed epidermal keratinocytes in culture. Biochem Biophys Res Commun. 1991;180(2):673–80.

    Article  CAS  PubMed  Google Scholar 

  11. Shimizu H, Ishiko A, Masunaga T, Kurihara Y, Sato M, Bruckner-Tuderman L, et al. Most anchoring fibrils in human skin originate and terminate in the lamina densa. Lab Invest. 1997;76(6):753–63.

    CAS  PubMed  Google Scholar 

  12. Brittingham R, Uitto J, Fertala A. High-affinity binding of the NC1 domain of collagen VII to laminin 5 and collagen IV. Biochem Biophys Res Commun. 2006;343(3):692–9.

    Article  CAS  PubMed  Google Scholar 

  13. Chen M, Marinkovich MP, Veis A, Cai X, Rao CN, O’Toole EA, et al. Interactions of the amino-terminal Noncollagenous (NC1) domain of type VII collagen with Extracellular Matrix Components. J Biol Chem. 1997;272(23):14516–22.

    Article  CAS  PubMed  Google Scholar 

  14. Uitto J, Bruckner-Tuderman L, Christiano AM, McGrath JA, Has C, South AP et al. Progress toward Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015. Journal of Investigative Dermatology. 2016;136(2):352–8.

  15. Kudva P, Jain R. Periodontal manifestation of epidermolysis bullosa: looking through the lens. J Indian Soc Periodontol. 2016;20(1):72.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Rashidghamat E, McGrath JA. Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa. IRDR. 2017;6(1):6–20.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Li H, Durbin R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics. 2009;25(14):1754–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297–303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164–164.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625(7993):92–100.

    Article  CAS  PubMed  Google Scholar 

  21. Krumm N, Sudmant PH, Ko A, O’Roak BJ, Malig M, Coe BP, et al. Copy number variation detection and genotyping from exome sequence data. Genome Res. 2012;22(8):1525–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Kõressaar T, Lepamets M, Kaplinski L, Raime K, Andreson R, Remm M. Primer3_masker: integrating masking of template sequence with primer design software. Hancock J, editor. Bioinformatics. 2018;34(11):1937–8.

  23. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Lewis BP, Green RE, Brenner SE. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci U S A. 2003;100(1):189–92.

    Article  CAS  PubMed  Google Scholar 

  25. Hughes K, Maloy SR. Brenner’s encyclopedia of genetics. 2 ed. London [u.a.]: Academic, Elsevier Science;; 2013.

    Google Scholar 

  26. Bruckner-Tuderman L, Nilssen O, Zimmermann DR, Dours-Zimmermann MT, Kalinke DU, Gedde-Dahl T, et al. Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain. J Cell Biol. 1995;131(2):551–9.

    Article  CAS  PubMed  Google Scholar 

  27. Burgeson RE, Type VII, Collagen. Anchoring fibrils, and Epidermolysis Bullosa. J Invest Dermatology. 1993;101(3):252–5.

    Article  CAS  Google Scholar 

  28. Rousselle P, Keene DR, Ruggiero F, Champliaud MF, Rest MVD, Burgeson RE. Laminin 5 binds the NC-1 domain of type VII collagen. J Cell Biol. 1997;138(3):719–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Lee Y-Y, Pulkkinen J, Liu L, Chen HS, Uitto YF. A Glycine-to-arginine substitution in the Triple-Helical Domain of Type VII Collagen in a family with Dominant Dystrophic Epidermolysis Bullosa Pruriginosa. J Invest Dermatology. 1997;108(6):947–9.

    Article  CAS  Google Scholar 

  30. Christiano AM, Uitto J. Molecular complexity of the cutaneous basement membrane zone: revelations from the paradigms of epidermolysis bullosa. Exp Dermatol. 1996;5(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  31. Khan FF, Khan N, Rehman S, Ejaz A, Ali U, Erfan M, et al. Identification and computational analysis of Novel pathogenic variants in Pakistani families with diverse Epidermolysis Bullosa Phenotypes. Biomolecules. 2021;11(5):620.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Fozia F, Nazli R, Alrashed MM, Ghneim HK, Haq ZU, Jabeen M, et al. Detection of Novel Biallelic causative variants in COL7A1 gene by whole-exome sequencing, resulting in congenital recessive Dystrophic Epidermolysis Bullosa in three unrelated families. Diagnostics. 2022;12(7):1525.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Christiano AM, Anton-Lamprecht I, Amano S, Ebschner U, Burgeson RE, Uitto J. Compound heterozygosity for COL7A1 mutations in twins with dystrophic epidermolysis bullosa: a recessive paternal deletion/insertion mutation and a dominant negative maternal glycine substitution result in a severe phenotype. Am J Hum Genet. 1996;58(4):682–93.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

S.S has a scholarship from the Higher Education Commission (international research support initiative program) in Pakistan.

Funding

The research work was awarded by Higher Education Commission (HEC), international research support initiative program (IRSIP), Islamabad, Pakistan.

Author information

Authors and Affiliations

Authors

Contributions

SS: collect blood sample and obtain consent from the affected family, conducted research, analyzed data and wrote the main manuscript text. UmK is the co-corresponding author, design study, research supervisor. SK: Co-Supervised the research work, IS: is the co-host supervisor, corresponding author and senior board member of BMC Medical Genomics, help in manuscript text, images and table designing and review literature. SL: is the senior host supervisors of the research project, keenly evaluate the whole project and manuscript text, images and tables. AA and TB help in variant selection and lab work. All authors evaluate the manuscript.

Corresponding authors

Correspondence to Umm-e- Kalsoom or Isabelle Schrauwen.

Ethics declarations

Ethics approval and consent to participate

The research study was approved by Institutional review board of Hazara University, Mansehra, Pakistan (IF.No.HU/ORIC/2023/1230) and Columbia University New York, USA (AAAS3431). Informed written consent was taken from participating members of family. Blood sampling from unaffected and affected individuals were carried out according to guidelines provided by Declaration of Helsinki.

Consent for publication

We hereby provide our explicit consent for the publication of our research materials, including clinical details and images, on behalf of patients who have given written consent for publication, subject to approval by the Board of BMC Medical Genomics.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sattar, S., Bharadwaj, T., Kalsoom, Ue. et al. A pathogenic COL7A1 variant highlights semi-dominant inheritance in dystrophic epidermolysis bullosa. BMC Med Genomics 18, 26 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12920-024-02077-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12920-024-02077-1